[Mick]

Now, in a research paper published Thursday, Stanford researchers say they’ve accomplished what Theranos was unable to do: they’ve developed a new approach that can measure thousands of molecules with about one drop of blood.

Genetics department chair and senior author Michael Snyder said his lab has combined a microsampling device with multi-omnic technology, a biological analysis approach, to measure thousands of molecules from 10 microliters of blood (about a single drop).

“I call it ‘Theranos that works,’” Snyder said. “Medicine is very antiquated; now, you go to a physician, they draw lots of blood, they measure 10 to 15 things. What we’re trying to do is measure thousands of molecules so we get a much clearer picture of what’s going on.”
...
“Theranos was saying, ‘I will disrupt healthcare, I will change clinical practice, I will change the way that medicine is done,’” Ioanndis said. “This research is still preliminary. There needs to be many other studies before I can say that this is something that you can take to medical care application.”

https://stanforddaily.com/2023/01/20/sta...an-20-2023

Curious to know what Dr. Phyllis Gardner thinks of this...

Phyllis Gardner (clinical pharmacologist)

[Mick]

Now, in a research paper published Thursday, Stanford researchers say they’ve accomplished what Theranos was unable to do: they’ve developed a new approach that can measure thousands of molecules with about one drop of blood.

Genetics department chair and senior author Michael Snyder said his lab has combined a microsampling device with multi-omnic technology, a biological analysis approach, to measure thousands of molecules from 10 microliters of blood (about a single drop).

“I call it ‘Theranos that works,’” Snyder said. “Medicine is very antiquated; now, you go to a physician, they draw lots of blood, they measure 10 to 15 things. What we’re trying to do is measure thousands of molecules so we get a much clearer picture of what’s going on.”
...
“Theranos was saying, ‘I will disrupt healthcare, I will change clinical practice, I will change the way that medicine is done,’” Ioanndis said. “This research is still preliminary. There needs to be many other studies before I can say that this is something that you can take to medical care application.”

https://stanforddaily.com/2023/01/20/sta...an-20-2023

Curious to know what Dr. Phyllis Gardner thinks of this...

Phyllis Gardner (clinical pharmacologist)